癌胚抗原（CEA）：其作为癌症管理中一种标志物的作用。
CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
作者信息
Goldenberg D M, Neville A M, Carter A C, Go V L, Holyoke E D, Isselbacher K J, Schein P S, Schwartz M
出版信息
J Cancer Res Clin Oncol. 1981;101(3):239-42. doi: 10.1007/BF00410109.
A consensus Development Conference was held at the National Institutes of Health from September 29-October 1, 1980, to address issues concerning the role of carcinoembryonic antigen (CEA) as a marker in the management of cancer. The panel met following formal presentations and discussions to assess the issues based on the evidence presented. These issues included: Should CEA be used in cancer screening? Is CEA helpful in cancer diagnosis? What does CEA tell about the extent and outcome of cancer? Is CEA helpful in monitoring cancer treatment? This paper constitutes the panel's findings.
1980年9月29日至10月1日，美国国立卫生研究院召开了一次共识发展会议，以探讨癌胚抗原（CEA）作为癌症管理标志物的作用相关问题。在正式报告和讨论之后，专家小组召开会议，根据所提供的证据对这些问题进行评估。这些问题包括：CEA是否应用于癌症筛查？CEA对癌症诊断有帮助吗？CEA能说明癌症的范围和预后情况吗？CEA对监测癌症治疗有帮助吗？本文构成了专家小组的研究结果。
Zotero 插件